Cargando…
SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January–March 2021
Between December 2020 and March 2021, we measured anti-SARS-CoV-2 IgG titres among 725 Israeli hospital workers vaccinated against COVID-19. Infection post-dose 1 vaccination did not increase IgG titres, and individuals infected post-dose 1 had IgG levels comparable to never-infected individuals who...
Autores principales: | Abu Jabal, Kamal, Ben-Amram, Hila, Beiruti, Karine, Brimat, Ira, Abu Saada, Ashraf, Bathish, Younes, Sussan, Christian, Zarka, Salman, Edelstein, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632408/ https://www.ncbi.nlm.nih.gov/pubmed/34399868 http://dx.doi.org/10.1017/S0950268821001928 |
Ejemplares similares
-
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021) -
Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020–October 2021
por: Edelstein, Michael, et al.
Publicado: (2022) -
Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021) -
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
por: Kuodi, Paul, et al.
Publicado: (2022) -
Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel
por: Kuodi, Paul, et al.
Publicado: (2023)